Rocket Pharmaceuticals, Inc. is a company in the U.S. stock market and it is a holding in 31 U.S.-traded ETFs. RCKT has around 2.4M shares in the U.S. ETF market. The largest ETF holder of RCKT is the iShares Russell 2000 ETF (IWM), with approximately 655.25K shares. Investors may also find of interest that the ETF with the largest allocation to RCKT stock is Virtus LifeSci Biotech Clinical Trials ETF (BBC), with a portfolio weight of 1.06%. On average, U.S. ETFs allocate 0.11% of RCKT to their portfolios.
Additionally, RCKT is a favorite stock for Vanilla and Exchange-specific ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with RCKT as a holding is the Principal Healthcare Innovators Index ETF (BTEC), with a return of 17.23%.